CBD: scientific definition of cannabidiol, origin, legal framework and limitations of current knowledge

What is CBD? A simple, scientific definition

CBD is short for cannabidiol. It is a molecule naturally present in the hemp plant, belonging to the cannabinoid family. Cannabinoids are chemical compounds produced by Cannabis sativa L. They are concentrated mainly in the flowers, in the trichomes, small resinous glands visible on the surface of the plant.

Cannabidiol is often described as a non-psychoactive cannabinoid. This means that it does not produce the euphoric or intoxicating effects associated with THC. It should therefore not be confused with tetrahydrocannabinol, the main molecule responsible for the psychoactive effects of THC-rich cannabis.

CBD can be found in various forms: in the raw plant, in hemp extract, in oil, in purified isolate, in cosmetic preparations, or in certain regulated products. The term CBD therefore sometimes refers to the molecule itself, sometimes to an ingredient, and sometimes to a finished product. This distinction is important because not all CBD-containing products fall under the same regulatory framework.

To delve deeper into the botanical background, also consult our internal guide:
Hemp: history, botany and uses.

Botanical origin of CBD: a molecule derived from hemp

CBD comes from hemp, a plant used for millennia for its fibers, seeds, vegetable oil, and industrial applications. Industrial hemp is selected to meet specific criteria, including a low THC content. This selection process distinguishes varieties intended for agricultural, textile, food, or wellness uses from varieties rich in THC.

In the plant, CBD does not always appear directly in its final form. It is often present in an acidic form, called CBDA, or cannabidiolic acid. Under the influence of heat, time, or certain processes, CBDA can be transformed into CBD. This phenomenon is called decarboxylation.

The natural CBD content of a plant depends on many factors: genetics, variety, growing conditions, light, soil, climate, harvest maturity, drying, curing, and storage. Therefore, two hemp flowers can have very different profiles, even if they belong to the same botanical species.

Trichomes, terpenes and the plant's natural profile

Trichomes play a central role in the composition of hemp. They produce and store a large portion of the cannabinoids and terpenes. Terpenes are aromatic compounds naturally present in many plants. They contribute to the aroma of hemp, with notes that can be reminiscent of citrus, pine, spices, earth, flowers, or fruit.

Understanding CBD therefore requires looking at the plant as a whole. Cannabidiol is not isolated from its botanical environment: it coexists with other molecules, some of which can influence the overall profile of an extract or product.

CBD and cannabinoids: a family of complex molecules

CBD belongs to a larger family called cannabinoids. Several dozen cannabinoids have been identified in Cannabis sativa L. Among the best known are CBD, THC, CBG, CBC, and CBN. Each cannabinoid has a specific structure and interaction profile.

• CBD: cannabidiol, non-psychotropic, studied for its potential biological interactions.
• THC: tetrahydrocannabinol, psychotropic, strictly regulated.
• CBG: cannabigerol, often presented as a precursor cannabinoid.
• CBN: cannabinol, a cannabinoid that can appear with the oxidation or evolution of THC.
• CBC: cannabichromene, a lesser-known cannabinoid that is still being studied.

In a CBD product, the exact composition depends on the type of extract used. An isolate contains essentially purified CBD. A broad-spectrum extract contains several hemp compounds, but without detectable THC, depending on the methods used. A full-spectrum extract retains a wider range of cannabinoids and terpenes, with the amount of THC remaining within the limits of applicable regulations.

This difference is essential for understanding a product's quality. A high CBD content is not the only relevant criterion. Spectrum, analysis, traceability, product stability, and regulatory compliance are equally important.

Read also:
CBD full spectrum, broad spectrum and isolate: understanding the differences.

CBD and THC: two molecules often confused, but very different

CBD and THC are both cannabinoids derived from hemp or cannabis. Their shared botanical origin explains the frequent confusion. However, their effects, status, and perception are very different.

THC is known for its psychoactive effects. It can alter perception, mood, alertness, coordination, and short-term memory. This property explains its classification under much stricter regulations. CBD, on the other hand, does not produce this euphoric effect. This distinction is central to the development of the cannabidiol market in Europe.

The Court of Justice of the European Union has issued an important ruling in Case C-663/18 concerning cannabidiol. This decision has helped to clarify the status of CBD under European law.
See the CJEU ruling on cannabidiol.

For further reading:
CBD vs THC: differences, effects and legality.

CBD and the endocannabinoid system: why this molecule is of interest to research

The endocannabinoid system is a biological network found in mammals. It includes receptors, molecules naturally produced by the body, and enzymes responsible for their synthesis or degradation. This system contributes to internal balance, sometimes called homeostasis.

The most frequently cited receptors are CB1 and CB2. CB1 receptors are primarily associated with the central nervous system, while CB2 receptors are more closely linked to the immune system and peripheral tissues. THC acts directly on certain receptors, particularly CB1, which explains its psychotropic effects.

CBD appears to have a more indirect mechanism of action. It doesn't simply act on a single receptor. Researchers are studying its potential interactions with multiple biological pathways. This complexity explains why CBD is often described as a modulating molecule rather than a simple receptor activator.

This topic deserves a dedicated reading:
The endocannabinoid system: biological role and interactions with CBD.

What science says about CBD: benefits, caution, and limitations

CBD is the subject of significant scientific interest. Research is focusing on its safety profile, biological interactions, pharmacology, potential effects, and limitations. However, the existence of studies does not mean that all CBD products can claim medicinal effects.

The World Health Organization has published a critical report on cannabidiol. This document indicates, in particular, that pure CBD does not appear to present a potential for abuse or addiction comparable to some controlled substances.
Read the official World Health Organization publication on cannabidiol.

It is also possible to consult scientific publications indexed on PubMed in order to observe the diversity of research carried out around cannabidiol:
Consult scientific publications on cannabidiol in PubMed.

Why caution remains necessary

CBD is sometimes presented in an exaggerated way in some marketing materials. However, caution is essential. Products available on the market should not be presented as treatments for anxiety, pain, insomnia, inflammatory diseases, or any other condition, except within a specific medical context and with appropriate authorization.

The effects experienced can vary greatly from person to person. They depend on the product, the concentration, individual sensitivity, metabolism, context, lifestyle habits, and any ongoing treatments.

The main forms of CBD: understanding without confusing them

CBD can be found in different types of products. Each format has its own specific use, regulations, and level of control. Therefore, it's important not to lump all forms of CBD into the same category.

CBD flowers

CBD flowers are hemp flowers that naturally contain cannabinoids and terpenes. Their legal status has been the subject of much debate in France. The Council of State overturned the general and absolute ban on the sale of cannabis flowers and leaves with low THC content, notably considering that CBD does not have the psychotropic properties of THC.
Read the Council of State's decision on CBD flowers and leaves.

CBD oils

CBD oils typically combine a hemp extract with a carrier oil. They can be full spectrum, broad spectrum, or formulated with an isolate. Their composition should be clear, particularly regarding the CBD concentration, the type of extract, and compliance with the regulatory THC limit.

Extracts and isolates

Hemp extracts can vary in concentration. CBD isolate refers to a purified form of cannabidiol. Broad-spectrum and full-spectrum extracts contain a higher concentration of hemp compounds. In all cases, laboratory analysis is essential to verify the product's actual composition.

CBD cosmetics

CBD cosmetics fall under a different set of regulations, as they are intended for external application. They must comply with the requirements applicable to cosmetic products, particularly regarding safety, labeling, and permitted ingredients.

CBD quality: analysis, traceability and transparency

The quality of a CBD product cannot be assessed solely based on a displayed percentage. A reputable product should be accompanied by precise information: hemp origin, type of extract, cannabinoid content, THC content, method of analysis, batch number, testing date, and laboratory used.

Why analyses are essential

The analyses verify that the advertised composition matches reality. They can measure cannabinoids, check the THC level, and detect certain contaminants depending on the tests performed. They are particularly important in an industry where products, formulations, and practices can vary significantly.

Traceability and accountability

Reliable traceability allows a product to be tracked from raw materials to the finished product. It strengthens consumer confidence and reduces the risk of non-compliance. In an EEAT (Environmental, Economic, and Territorial) approach, transparency is a key signal: a website that explains, sources, and provides context inspires more confidence than one that makes promises without proof.

Also read:
Quality, analysis and traceability of CBD: how to read a product seriously.

CBD is legal in France and Europe: the key points

In France, CBD is authorized under certain conditions. The framework is based in particular on the decree of December 30, 2021, which stipulates that the delta-9-THC content of hemp extracts and products containing them must not exceed 0.30%. This threshold does not mean that a product is automatically compliant in all cases: labeling, product category, marketing presentation, and the intended use remain equally important.

Official source:
Decree of December 30, 2021 on Légifrance.

In Europe, the circulation of CBD must also be understood through the case law of the Court of Justice of the European Union and the rules relating to food, cosmetics and products containing hemp extracts.

For a detailed guide:
CBD legal in France and Europe: complete regulatory framework.

CBD and Novel Food: a major European issue

Novel Food status applies to foods or ingredients that were not consumed in significant quantities in the European Union before May 15, 1997. Cannabinoids and certain hemp extracts may fall under this category when used in food or food supplements.

The European Commission's Novel Food catalogue allows you to check the status of many ingredients:
Consult the European Commission's Novel Food catalogue.

In February 2026, EFSA published an update on the provisional safety level of cannabidiol as a Novel Food, concerning specific formulations of food supplements based on purified CBD.
Read the EFSA publication on cannabidiol as a Novel Food.

This question is important because it shows that CBD should not be treated as a simple ingredient. Depending on the product's form, use, and presentation, the regulations may differ.

Precautions regarding CBD: what you need to know

Even when CBD is legal and properly marketed, certain precautions are still necessary. CBD can interact with some medications. People undergoing treatment should consult a healthcare professional before use. This caution is especially important for treatments metabolized by certain liver enzymes.

Pregnant or breastfeeding women, minors, vulnerable individuals, and those with pre-existing medical conditions should also avoid trivializing CBD. It should not be presented as a universal solution.

CBD and driving

Driving requires extra caution. Even a legal CBD product can contain traces of THC within the permitted limits. THC can be detected during roadside checks. Therefore, it's important to clearly inform readers: legal does not mean risk-free.

CBD and medical claims

Responsible content should avoid medical claims. Claiming that CBD “cures,” “treats,” or “addresses” a disease can be misleading and legally problematic. A serious approach prioritizes cautious wording, reliable sources, and a clear distinction between scientific research, wellness use, and medical applications.

FAQ: Frequently asked questions about CBD

Is CBD a drug?

CBD does not produce the psychoactive effects of THC. In France, it may be authorized under certain conditions, particularly when the product complies with the applicable regulatory framework and the permitted THC threshold. However, it must not be misrepresented or presented as a medication.

Does CBD get you high?

No. CBD is not known to produce the euphoric effect associated with THC. This is one of the major differences between cannabidiol and tetrahydrocannabinol.

What is the difference between CBD and THC?

CBD is a non-psychoactive cannabinoid. THC is a strictly regulated psychoactive cannabinoid. They both come from Cannabis sativa L., but their effects and status are very different.

Is CBD legal in France?

CBD is permitted under certain conditions. Hemp extracts and products containing them must, in particular, comply with the 0.30% delta-9-THC threshold stipulated by the decree of December 30, 2021. Other rules may apply depending on the type of product.

Is CBD a medicine?

Commercially available CBD products should not be presented as medicines. They are not a substitute for medical treatment or advice.

Can CBD interact with medications?

Yes, interactions are possible with certain treatments. People taking medication should consult a healthcare professional before use.

Why are laboratory analyses important?

The analyses allow verification of a product's actual composition: CBD level, THC level, presence of other cannabinoids and, depending on the tests, any potential contaminants. They are essential for transparency and compliance.

What is CBD Novel Food?

Novel Food status applies to certain foods or ingredients considered new in the European Union. Food products containing CBD or certain hemp extracts may fall under this category.